Drugs & Aging

, Volume 15, Issue 2, pp 103–116 | Cite as

Xerostomia and Hyposalivation

Causes, Consequences and Treatment in the Elderly
Review Article

Abstract

Xerostomia and salivary gland hypofunction (SGH) are prevalent in elderly populations, causing much discomfort and even difficulties in eating. SGH also increases the occurrence and severity of oral diseases and makes the patient susceptible to candidiasis. The principal causes of SGH and xerostomia are systemic diseases and drugs used daily. The diagnosis of SGH and xerostomia is based on simple methods, of which measuring both unstimulated and stimulated salivary flow rate is the most important. Treatment calls for proper management of underlying disease, avoidance of all unnecessary medications, and topical remedies such as artificial saliva substitutes. However, good hydration is essential in the elderly with SGH and xerostomia, and water is the drink of choice. In extremely difficult cases, for instance in patients receiving radiotherapy for cancer of the head and neck regions, parasympathomimetic drugs may be administered if no contraindications exist.

Keywords

Salivary Gland Adis International Limited Oral Health Salivary Flow Salivary Flow Rate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fox PC, van der Ven PF, Sonies BC, et al. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985; 110(4): 519–25PubMedGoogle Scholar
  2. 2.
    Sreebny LM, Valdini A. Xerostomia part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988; 66(4): 451–8PubMedCrossRefGoogle Scholar
  3. 3.
    Sreebny LM, Valdini A, Yu A. Xerostomia part II: relationship to nonoral symptoms, drugs and diseases. Oral Surg Oral Med Oral Pathol 1989; 68(4): 419–27PubMedCrossRefGoogle Scholar
  4. 4.
    McDonald E, Marino C. Dry mouth: diagnosing and treating its multiple causes. Geriatrics 1991; 46(3): 61–3PubMedGoogle Scholar
  5. 5.
    Närhi TO. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res 1994; 73(1): 20–5PubMedCrossRefGoogle Scholar
  6. 6.
    Nederfors T, Isaksson R, Mornstad H, et al. Prevalence of perceived symptoms of dry mouth in an adult Swedish population: relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 1997; 25(3): 211–6PubMedCrossRefGoogle Scholar
  7. 7.
    Loesche WJ, Bromberg J, Terpenning MS, et al. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. J Am Geriatr Soc 1995; 43(4): 401–7PubMedGoogle Scholar
  8. 8.
    Parvinen T, Parvinen I, Larmas M. Stimulated salivary flow rate, pH and lactobacillus and yeast concentrations in medicated persons. Scand J Dent Res 1984; 92(6): 524–32PubMedGoogle Scholar
  9. 9.
    Schubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987; 66: 680–8PubMedGoogle Scholar
  10. 10.
    Atkinson JC, Travis WD, Pillemer SR, et al. Major salivary gland function in primary Sjögren’s syndrome and its relationship to clinical features. J Rheumatol 1990; 18(1): 318–22Google Scholar
  11. 11.
    Närhi TO, Meurman JH, Ainamo A, et al. Association between salivary flow rate and the use of systemic medication among 76-, 81- and 86-year-old inhabitants in Helsinki, Finland. J Dent Res 1992; 71(12): 1875–80PubMedCrossRefGoogle Scholar
  12. 12.
    Valdez IH, Atkinson JC, Ship JA, et al. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 1993; 25(1): 41–7PubMedCrossRefGoogle Scholar
  13. 13.
    Österberg T, Landahl S, Hedegård B. Salivary flow, saliva, pH and buffering capacity in 70- year-old men and women: correlation to dental health, dryness in the mouth, disease and drug treatment. J Oral Rehabil 1984; 11(2): 157–70PubMedCrossRefGoogle Scholar
  14. 14.
    Pajukoski H, Meurman JH, Snellman-Gråhn S, et al. Salivary flow and composition in elderly patients referred to an acute geriatric ward. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84(3): 265–71PubMedCrossRefGoogle Scholar
  15. 15.
    Abu-Shara KA, Ghareeb MA, Zaher S, et al. Radiotherapeutic effect on oropharyngeal flora in patients with head and neck cancer. J Laryngol Otol 1993; 107(3): 222–7PubMedCrossRefGoogle Scholar
  16. 16.
    Brown LR, Dreitzen S, Daly TE, et al. Interrelations of oral microorganisms, immunoglobulins, and dental caries following radiotherapy. J Dent Res 1978; 57(9–10): 882–93PubMedGoogle Scholar
  17. 17.
    Meurman JH. Dental infections and general health. Quintessence Int 1997; 28(12): 807–11PubMedGoogle Scholar
  18. 18.
    Meurman JH, Pyrhonen S, Teerenhovi L, et al. Oral sources of septicaemia in patients with malignancies. Oral Oncol 1997; 33(6): 389–97PubMedCrossRefGoogle Scholar
  19. 19.
    Herrera JL, Lyons 2nd MF, Johnson LF. Saliva: its role in health and disease. J Clin Gastroenterol 1988; 10(5): 569–78PubMedCrossRefGoogle Scholar
  20. 20.
    Tenovuo J. Oral defense factors in the elderly. Endod Dent Traumatol 1992; 8(3): 93–8PubMedCrossRefGoogle Scholar
  21. 21.
    Baum BJ, Ship JA, Wu AJ. Salivary gland function and aging: a model for studying the interaction of aging and systemic disease. Crit Rev Oral Biol Med 1992; 4(1): 53–64PubMedGoogle Scholar
  22. 22.
    Sreebny LM. Xerostomia (dry mouth). In: Sreebny LM, editor. The salivary system. BocaRaton (FL): CRC Press, 1987: 179–202Google Scholar
  23. 23.
    Wolff M, Kleinberg I. Oral mucosal wetness in hypo- and normosalivators. Arch Oral Biol 1998; 43(6): 455–62PubMedCrossRefGoogle Scholar
  24. 24.
    Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987; 115(4): 581–4PubMedGoogle Scholar
  25. 25.
    Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987; 66: 648–53PubMedGoogle Scholar
  26. 26.
    Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992; 71(7): 1363–9PubMedCrossRefGoogle Scholar
  27. 27.
    Spielman AI. Interaction of saliva and taste. J Dent Res 1990; 69(3): 838–43PubMedCrossRefGoogle Scholar
  28. 28.
    Rhodus NL, Brown J. The association of xerostomia and inadequate intake in older adults. J Am Diet Assoc 1990; 90(2): 1688–92PubMedGoogle Scholar
  29. 29.
    Mandel ID, Wotman S. The salivary secretions in health and disease. Oral Sci Rev 1976; 8: 25–47PubMedGoogle Scholar
  30. 30.
    Adams D. The mucus barrier and absorption through the oral mucosa. J Dent Res 1975; 54: B19–26PubMedCrossRefGoogle Scholar
  31. 31.
    Tabak LA, Levine MJ, Mandel ID, et al. Role of salivary mucins in the protection of the oral cavity. J Oral Pathol 1982; 11(1): 1–17PubMedCrossRefGoogle Scholar
  32. 32.
    Tenovuo J. Nonimmunoglobulin defence factors in human saliva. In: Tenovuo JO, editor. Human saliva: clinical chemistry and microbiology. Vol. II. Boca Raton (FL): CRC Press, 1989: 55–91Google Scholar
  33. 33.
    Brandtzaeg P. Salivary immunoglobulins. In: Tenovuo JO, editor. Human saliva: clinical chemistry and microbiology. Vol. II. Boca Raton (FL): CRC Press Inc, 1989: 1–54Google Scholar
  34. 34.
    Dawes C. Factors influencing in salivary flow rate and composition. In: Edgar WM, O’Mullane DM, editors. Saliva and oral health. 2nd ed. London: British Dental Association, 1996: 27–41Google Scholar
  35. 35.
    Baum BJ. Neurotransmitter control of secretion. J Dent Res 1987; 66: 628–32PubMedGoogle Scholar
  36. 36.
    Thaysen JH, Thorn NA, Schwartz IL. Excretion of sodium, potassium, chloride and carbon oxide in human parotid saliva. Am J Physiol 1954; 178: 155–9PubMedGoogle Scholar
  37. 37.
    Kerr AC, editor. The physiological regulation of salivary secretion in man [international series of monographs on oral biology; 1]. Oxford: Pregamon Press, 1961Google Scholar
  38. 38.
    Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 1989; 119(2): 298–304PubMedGoogle Scholar
  39. 39.
    Parvinen T, Larmas M. Age dependency of stimulated salivary flow rate, pH and lactobacillus and yeast concentrations. J Dent Res 1982; 61(9): 1052–5PubMedCrossRefGoogle Scholar
  40. 40.
    Persson RE, Izutsu KT, Treulove EL, et al. Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surg Oral Med Oral Pathol 1991; 72(1): 42–6PubMedCrossRefGoogle Scholar
  41. 41.
    Ericsson Y, Hardwich L. Individual diagnosis, prognosis and counselling for caries prevention. Caries Res 1978; 12Suppl. 1: 94–102PubMedCrossRefGoogle Scholar
  42. 42.
    Sreebny LM. Xerostomia: diagnosis, management and clinical complications. In: Edgar WM, OÌMullane DM, editors. Saliva and oral health. 2nd ed. London: British Dental Association, 1996: 43–66Google Scholar
  43. 43.
    Ship JA, Fox PC, Baum BJ. How much saliva is enough? Normal function defined. J Am Dent Assoc 1991; 122(3): 63–9PubMedGoogle Scholar
  44. 44.
    Scott J. Quantitative age changes in the histological structure of the human submandibular salivary glands. Arch Oral Biol 1977; 22(3): 221–7PubMedCrossRefGoogle Scholar
  45. 45.
    Baum BJ. Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res 1981; 60(7): 1292–6PubMedCrossRefGoogle Scholar
  46. 46.
    Tylenda CA, Ship JA, Fox PC, et al. Evaluation of submandibular salivary flow rate in different age groups. J Dent Res 1988; 67(9): 1225–8PubMedCrossRefGoogle Scholar
  47. 47.
    Pedersen W, Schubert M, Izutsu K, et al. Age-dependent decreases in human submandibular gland flow rates as measured under resting and post-stimulation conditions. J Dent Res 1985; 64(5): 822–5PubMedCrossRefGoogle Scholar
  48. 48.
    Österberg T, Birkhed D, Johansson C, et al. Longitudinal study of stimulated whole saliva in an elderly population. Scand J Dent Res 1992; 100(6): 340–5PubMedGoogle Scholar
  49. 49.
    Gilbert GH, Minaker KL. Principles of surgical risk assessment of the elderly patient. J Oral Maxillofac Surg 1990; 48(9): 972–9PubMedCrossRefGoogle Scholar
  50. 50.
    Scott J. Structural age changes in the salivary glands. In: Ferguson DB, editor. The aging mouth. Basel: Karger, 1987: 40–62Google Scholar
  51. 51.
    Denny PC, Denny PA, Klauser DK, et al. Age-related changes in mucins from human whole saliva. J Dent Res 1991; 70(10): 1320–7PubMedCrossRefGoogle Scholar
  52. 52.
    Navazesh M, Mulligan RA, Kipnis V, et al. Comparison of whole saliva flow rates and mucin concentrations in healthy Caucasian young and aged adults. J Dent Res 1992; 71(6): 1275–8PubMedCrossRefGoogle Scholar
  53. 53.
    Baum BJ, Kousvelari EE, Oppenheim FG. Exocrine protein secretion from human parotid glands during aging: stable release of the acidic proline-rich proteins. J Gerontol 1982; 37(4): 392–5PubMedGoogle Scholar
  54. 54.
    Fox PC, Heft MW, Herrera M, et al. Secretion of antimicrobial proteins from the parotid glands of different aged healthy persons. J Gerontol 1987; 42(5): 466–9PubMedGoogle Scholar
  55. 55.
    Smith DJ, Taubman MA, Ebersole JL. Ontogeny and senescence of salivary immunity. J Dent Res 1987; 66(2): 451–6PubMedCrossRefGoogle Scholar
  56. 56.
    Carlèn A, Olsson J, Ramberg P. Saliva mediated adherence, aggregation and prevalence in dental plaque of Streptococcus mutans, Streptococcus sanquis and Actinomyces spp. in young and elderly humans. Arch Oral Biol 1996; 41(12): 1133–40PubMedCrossRefGoogle Scholar
  57. 57.
    Rudney JD, Krig MA, Neuvar EK, et al. Antimicrobial proteins in human unstimulated whole saliva in relation to each other, and to measures of health status, dental plaque accumulation and composition. Arch Oral Biol 1991; 36(7): 497–506PubMedCrossRefGoogle Scholar
  58. 58.
    Streckfus CF, Welsh S, Strahl RC. Diminution of parotid IgA secretion in an elderly black population taking antihypertension medications. Oral Surg Oral Med Oral Pathol 1991; 71(1): 50–4PubMedCrossRefGoogle Scholar
  59. 59.
    Närhi TO, Tenovuo J, Ainamo A, et al. Antimicrobial factors, sialic acid, and protein concentration in whole saliva of the elderly. Scand J Dent Res 1994; 102(2): 120–5PubMedGoogle Scholar
  60. 60.
    Atkinson JC, Fox PC. Sjögren’s syndrome: oral and dental considerations. J Am Dent Assoc 1993; 124(3): 74–6,78-82,84-6PubMedGoogle Scholar
  61. 61.
    Ship JA, Fischer DJ. The relationship between dehydration and parotid salivary gland function in young and older healthy adults. J Gerontol A Biol Sci Med Sci 1997; 52(5): M310–9PubMedCrossRefGoogle Scholar
  62. 62.
    Bergdahl M, Bergdahl J, Johansson I. Depressive symptoms in individuals with idiopathic subjective dry mouth. J Oral Pathol Med 1997; 26(10): 448–50PubMedCrossRefGoogle Scholar
  63. 63.
    Ship JA, DeCarli C, Friedland RP, et al. Diminished submandibular salivary flow in dementia of the Alzheimer type. J Gerontol 1990; 45(2): M61–6PubMedGoogle Scholar
  64. 64.
    Conner S, Iranpour B, Mills J. Alteration in parotid salivary flow in diabetes mellitus. Oral Surg Oral Med Oral Pathol 1970; 30(1): 55–9PubMedCrossRefGoogle Scholar
  65. 65.
    Ben-Aryeh H, Cohen M, Kanter Y, et al. Salivary composition in diabetic patients. J Diabet Complications 1988; 2(2): 96–9PubMedCrossRefGoogle Scholar
  66. 66.
    Cherry-Peppers G, Sorkin J, Andres R, et al. Salivary gland function and glucose metabolic status. J Gerontol 1992; 47(4): M130–4PubMedGoogle Scholar
  67. 67.
    Sreebny LM, Yu A, Green A, et al. Xerostomia in diabetes mellitus. Diabetes Care 1992; 15(7): 900–4PubMedCrossRefGoogle Scholar
  68. 68.
    Cherry-Peppers G, Ship JA. Oral health in patients with type II diabetes and impaired glucose tolerance. Diabetes Care 1993; 16(4): 638–41PubMedCrossRefGoogle Scholar
  69. 69.
    Närhi TO, Meurman JH, Ainamo A, et al. Oral health in the elderly with non-insulin-dependent diabetes mellitus. Spec Care Dentist 1996; 16(3): 116–22PubMedCrossRefGoogle Scholar
  70. 70.
    Meurman JH, Collin H-L, Niskanen L, et al. Saliva in non-insulin-dependent diabetic patients and control subjects. Oral Surg Oral Med Oral Pathol 1998; 85: 69–76Google Scholar
  71. 71.
    Bertram U, Kragh-Sörensen P, Rafaelsen OJ, et al. Saliva secretion following long-term antidepressant treatment with nortriptyline controlled by plasma levels. Scand J Dent Res 1979; 87(1): 58–64PubMedGoogle Scholar
  72. 72.
    Kreher JM, Graser GN, Handelman SL. The relationship of drug use to the denture function and saliva flow rate in a geriatric population. J Prosthet Dent 1987; 57(5): 631–8PubMedCrossRefGoogle Scholar
  73. 73.
    Levy SM, Baker KA, Semal TP, et al. Use of medications with dental significance by a non-institutionalized elderly population. Gerodontics 1988; 4(3): 119–25PubMedGoogle Scholar
  74. 74.
    Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3(4): 335–48PubMedCrossRefGoogle Scholar
  75. 75.
    Handelman SL, Barie JM, Espeland MA, et al. Prevalence of drugs causing hyposalivation in an institutionalized geriatric population. Oral Surg Oral Med Oral Pathol 1986; 62(1): 26–31PubMedCrossRefGoogle Scholar
  76. 76.
    Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth. Gerodontology 1986; 5(2): 75–99PubMedCrossRefGoogle Scholar
  77. 77.
    Hunter KD, Wilson WS. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 1995; 40(11): 983–9PubMedCrossRefGoogle Scholar
  78. 78.
    Volz-Zang C, Waldhauser T, Schulte B, et al. Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man. Eur J Clin Pharmacol 1995; 49(1–2): 45–9PubMedGoogle Scholar
  79. 79.
    Molander L, Birkhed D. Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects. Psychopharmacology (Berl) 1981; 75(2): 114–8CrossRefGoogle Scholar
  80. 80.
    Vargas R, McMahon FG, Ryan JR. A study of anticholinergic activity of terfenadine in normal volunteers. J Int Med Res 1989; 17(2): 157–61PubMedGoogle Scholar
  81. 81.
    Nederfors T, Dahlöf C. Effects on salivary flow rate and composition of withdrawal of and re-exposure to the β1-selective antagonist metoprolol in a hypertensive patient population. Eur J Oral Sci 1996; 104(3): 262–8PubMedCrossRefGoogle Scholar
  82. 82.
    Findlay D, Lawrence JR. An alternative method of assessing changes in salivary flow: comparison of the effects of Clonidine and tiamenidine (HOE 440). Eur J Clin Pharmacol 1978; 14(4): 231–5PubMedCrossRefGoogle Scholar
  83. 83.
    Hernandez YM, Raczkowski VF, Drectchen KL, et al. Cocaine inhibits sympathetic neural activity by acting in the central nervous system and at the sympathetic ganglion. J Pharmacol Exp Ther 1996; 277(2): 1114–21PubMedGoogle Scholar
  84. 84.
    Steiner JE, Birnbaum D, Karmeli F, et al. Effect of diazepam on human salivary secretion. Digestion 1970; 3(5): 262–8PubMedCrossRefGoogle Scholar
  85. 85.
    Nagler A, Nagler R, Ackerstein A, et al. Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT). Bone Marrow Transplant 1997; 20(7): 575–80PubMedCrossRefGoogle Scholar
  86. 86.
    Atkinson JC, Shiroky JB, Macynski A, et al. Effects of furosemide on the oral cavity. Gerodontol 1989; 8(1): 23–6CrossRefGoogle Scholar
  87. 87.
    Meurman JH, Laine P, Keinänen S, et al. Five-year follow-up study in patients treated for lymphoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83(4): 447–52PubMedCrossRefGoogle Scholar
  88. 88.
    Nederfors T, Twetman S, Dahlöf C. Effects of the thiazide diuretic bendro-flumethiazide on salivary flow rate and composition. Scand J Dent Res 1989; 97(6): 520–7PubMedGoogle Scholar
  89. 89.
    von Knorring L, Mörnstad H. Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission. Neuropsychobiology 1986; 15(3–4): 146–54CrossRefGoogle Scholar
  90. 90.
    Mörnstad H, von Knorring L, Forsgren L, et al. Acute effects of some different antidepressant drugs on saliva secretion and composition. Neuropsychobiology 1986; 15: 73–9PubMedCrossRefGoogle Scholar
  91. 91.
    Mörnstad H, von Knorring L, Forsgren L, et al. Long-term effects of two principally different antidepressant drugs on saliva secretion and composition. Scand J Dent Res 1986; 94(5): 461–70Google Scholar
  92. 92.
    Nederfors T, Dahlöf C, Ericson T, et al. Effects of the antihypertensive drug Captopril on human salivary secretion rate and composition. Eur J Oral Sci 1995; 103(6): 351–4PubMedCrossRefGoogle Scholar
  93. 93.
    Laurikainen K, Laurikainen E, Tenovuo J, et al. Effects of β-blocking agent, timolol maleate, on saliva in healthy volunteers. Scand J Dent Res 1988; 96(2): 121–7PubMedGoogle Scholar
  94. 94.
    Nederfors T, Dahlöf C. Effects of β-adrenoreceptor antagonist atenelol and propranolol on human whole saliva flow rate and composition. Arch Oral Biol 1992; 37(7): 579–84PubMedCrossRefGoogle Scholar
  95. 95.
    Nederfors T, Ericsson T, Twetman S, et al. Effects of the β-adrenoreceptor antagonists atenelol and propranolol on human parotid and submandibular-sublingual salivary secretion. J Dent Res 1994; 73(1): 5–10PubMedCrossRefGoogle Scholar
  96. 96.
    Nederfors T, Dahlöf C, Twetman S. Effects of the β-adrenoreceptor antagonists atenelol and propranolol on human unstimulated saliva flow rate and protein composition. Scand J Dent Res 1994; 102(4): 235–7PubMedGoogle Scholar
  97. 97.
    Lau KR, Howorth AJ, Case RM. The effects of bumetanide, amiloride and Ba2+ on fluid and electrolyte secretion in rabbit salivary gland. J Physiol (Lond) 1990; 425: 407–27Google Scholar
  98. 98.
    Hollmann M, Mller-Peltzer H, Greger G, et al. Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers. Pharmacopsychiatry 1987; 20(2): 72–7PubMedCrossRefGoogle Scholar
  99. 99.
    DeVault KR, Castell DO. Effects of antireflux therapies on salivary function in normal humans. Dig Dis Sci 1987; 32(6): 603–8PubMedCrossRefGoogle Scholar
  100. 100.
    Teichman SL, Ferrick A, Kim SG, et al. Disopyramide-pyridostigmine interaction: selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect. J Am Coll Cardiol 1987; 10(3): 633–41PubMedCrossRefGoogle Scholar
  101. 101.
    Johnson DA, Cortez JE. Chronic treatment with beta adrenergic agonists and antagonists alters the composition of proteins in rat parotid saliva. J Dent Res 1988; 67(8): 1103–8PubMedCrossRefGoogle Scholar
  102. 102.
    Dehpour AR, Ghafourifar P, Massoudi S, et al. On the relation of calcium channel blockers to rat parotid and submandibular glands function in vivo. Gen Pharmacol 1995; 26(3): 619–22PubMedCrossRefGoogle Scholar
  103. 103.
    von Knorring L. Changes in saliva secretion and accommodation width during short-term administration of imipramine and zimelidine in healthy volunteers. Int Pharmacopsychiatry 1981; 16(2): 69–78Google Scholar
  104. 104.
    Stanovnik L, Erjavec F. The inhibition of salivary secretion by histamine H2 antagonists: a study on the cat submandibular gland. Agents Actions 1983; 13(2–3): 196–9PubMedCrossRefGoogle Scholar
  105. 105.
    Volz HP, Gleiter CH. Monoamine oxidase inhibitors: a perspective on their use in the elderly. Drugs Aging 1998 13(5): 341–55PubMedCrossRefGoogle Scholar
  106. 106.
    Melsom M, Myren J, Larsen S, et al. Comparison of glucagon and pethidine plus atropine as premedication for peroral endoscopy: a double blind study. Endoscopy 1977; 9(2): 79–82PubMedCrossRefGoogle Scholar
  107. 107.
    Scarlett SM, Sagstràm S, Sagulin GB, et al. Effects of chronic furosemide treatment on rat exocrine glands. Exp Mol Pathol 1988; 48(2): 206–15PubMedCrossRefGoogle Scholar
  108. 108.
    Streckfus CF. Salivary function and hypertension: a review of the literature and a case report. J Am Dent Assoc 1995; 126(7): 1012–7PubMedGoogle Scholar
  109. 109.
    National Centre for Health Statistics. Drug utilization: national ambulatory medical care survey. Washington, DC: National Center for Health Statistics, 1988Google Scholar
  110. 110.
    Lassila HC, Stoeher GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother 1996; 30(6): 589–95PubMedGoogle Scholar
  111. 111.
    Landahl S. Drug treatment in 70–82-year-old persons: a longitudinal study. Acta Med Scand 1987; 221(2): 179–84PubMedCrossRefGoogle Scholar
  112. 112.
    Thorselius I, Emilson C-G, Österberg T. Salivary conditions and drug consumption in older age groups of elderly Swedish individuals. Gerodontics 1988; 4(2): 66–70PubMedGoogle Scholar
  113. 113.
    Thomson WM, Brown RH, Williams SM. Medication and perception of dry mouth in a population of institutionalized elderly people. N Z Med J 1993; 106(957): 219–21PubMedGoogle Scholar
  114. 114.
    Birkhed D, Heintze U. Salivary secretion, buffer capacity and pH. In: Tenovuo JO, editor. Human saliva: clinical chemistry and microbiology, volume 1. Boca Raton (FL): CRC Press, 1989: 25–73Google Scholar
  115. 115.
    Söderling E. Practical aspects of salivary analyses. In: Tenovuo JO, editor. Human saliva: chemical chemistry and microbiology. Vol. I. Boca Raton (FL): CRC Press, 1989: 1–24Google Scholar
  116. 116.
    Sreebny LM, Banoczy J, Baum BJ, et al. Saliva: its role in health and disease. Int Dent J 1992; 42Suppl. 2: 291–304Google Scholar
  117. 117.
    Rudney JD, Larson CJ. The prediction of saliva swallowing frequency in humans from estimates of salivary flow rate and the volume of saliva swallowed. Arch Oral Biol 1995; 40(6): 507–12PubMedCrossRefGoogle Scholar
  118. 118.
    Arendorf TM, Walker DM. The prevalence and intraoral distribution of Candida albicans in man. Arch Oral Biol 1980; 25(1): 1–10PubMedCrossRefGoogle Scholar
  119. 119.
    Parvinen T, Larmas M. The relation of stimulated salivary flow rate and pH to lactobacillus and yeast concentrations in saliva. J Dent Res 1981; 60(12): 1929–35PubMedCrossRefGoogle Scholar
  120. 120.
    Rask PI, Emilson CG, Krasse B, et al. Dental caries and salivary and microbial conditions in 50–60-year-old persons. Community Dent Oral Epidemiol 1991; 19(2): 93–7PubMedCrossRefGoogle Scholar
  121. 121.
    Närhi TO, Ainamo A, Meurman JH. Salivary yeasts, saliva, and oral mucosa in the elderly. J Dent Res 1993; 72(6): 1009–14PubMedCrossRefGoogle Scholar
  122. 122.
    Närhi TO, Ainamo A, Meurman JH. Mutans streptococci and lactobacilli in the elderly. Scand J Dent Res 1994; 102(2): 97–102PubMedGoogle Scholar
  123. 123.
    Wahlin YB. Salivary secretion rate, yeast cells, and oral candidosis in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 1991; 71(6): 689–95PubMedCrossRefGoogle Scholar
  124. 124.
    Meurman JH, Pajukoski H, Snellman S, et al. Oral infections in home-living elderly patients admitted to an acute geriatric ward. J Dent Res 1997; 76(6): 1271–6PubMedCrossRefGoogle Scholar
  125. 125.
    Holmstrup P, Axéll T. Classification and clinical manifestations of oral yeast infections. Acta Odontol Scand 1990; 48(1): 57–9PubMedCrossRefGoogle Scholar
  126. 126.
    Hase JC, Birkhed D, Lagerlöf F, et al. Oral retention of glucose at pharmacologically reduced salivary flow in man. Scand J Dent Res 1994; 102(3): 180–5PubMedGoogle Scholar
  127. 127.
    Risheim H, Arneberg P, Birkhed D. Oral sugar clearance and root caries prevalence in rheumatic patients with dry mouth symptoms. Caries Res 1992; 26(6): 439–44PubMedCrossRefGoogle Scholar
  128. 128.
    Fox PC. Differentiation of dry mouth etiology. Adv Dent Res 1996; 10(1): 13–6PubMedCrossRefGoogle Scholar
  129. 129.
    Jensen-Kjeilen JC, Brodin B, Aars H, et al. Parotid salivary flow in response to mechanical and gustatory stimulation in man. Acta Physiol Scand 1987; 131(2): 169–75PubMedCrossRefGoogle Scholar
  130. 130.
    Järvinen VK, Rytömaa II, Heinonen OP. Risk factors in dental erosion. J Dent Res 1991; 70(6): 942–7PubMedCrossRefGoogle Scholar
  131. 131.
    Meurman JH, Sorvari R, Pelttari A, et al. Hospital mouth-cleaning aids may cause dental erosion. Spec Care Dentist 1996; 16(6): 247–50PubMedCrossRefGoogle Scholar
  132. 132.
    Mäkinen KK, Mäkinen P-L, Chen C-Y, et al. Polyol-combinant saliva stimulants and oral health in Veterans Affairs patients: an exploratory study. Spec Care Dentist 1996: 16(3): 104–15PubMedCrossRefGoogle Scholar
  133. 133.
    Risheim H, Arneberg P. Salivary stimulation by chewing gum and lozenges in rheumatic patients with xerostomia. Scand J Dent Res 1993; 101(1): 40–3PubMedGoogle Scholar
  134. 134.
    Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995; 49(1): 143–55PubMedCrossRefGoogle Scholar
  135. 135.
    Johnson JT, Ferreti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993; 329(6): 390–5PubMedCrossRefGoogle Scholar
  136. 136.
    Rieke JW, Hafermann MD, Johnson JT. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 1995; 31(3): 661–9PubMedCrossRefGoogle Scholar
  137. 137.
    Joensuu H, Boström P, Makkonen T. Pilocarpine and carbacoline in treatment of radiation-induced xerostomia. Radiother Oncol 1993; 26(1): 33–7PubMedCrossRefGoogle Scholar
  138. 138.
    Bagheri H, Schmitt L, Berlan M, et al. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients with psychotropic drugs. Eur J Clin Pharmacol 1997; 52(5): 339–42PubMedCrossRefGoogle Scholar
  139. 139.
    Weiss WW, Brenman HS, Katz P, et al. Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg 1986; 44(11): 845–50PubMedCrossRefGoogle Scholar
  140. 140.
    Blom M, Dawidson I, Angmar-Mansson B. The effect of acupuncture on salivary flow rates in patients with xerostomia. Oral Surg Oral Med Oral Pathol 1992; 73(3): 293–8PubMedCrossRefGoogle Scholar
  141. 141.
    Schou L, Holm-Pedersen P, Lang NP. Preventive dental care for elderly people. In: Holm-Pedersen P, Löe H, editors. Textbook of geriatric dentistry. 2nd ed. Copenhagen: Munksgaard, 1996: 302–18Google Scholar
  142. 142.
    Dreizen S, Brown LR, Daly TE, et al. Prevention of xerostomiarelated dental caries in irradiated cancer patients. J Dent Res 1977; 56(2): 99–104PubMedCrossRefGoogle Scholar
  143. 143.
    Billings RJ, Meyerowitz C, Featherstone JDB, et al. Retention of topical fluoride in the mouths of xerostomic subjects. Caries Res 1988; 22(5): 306–10PubMedCrossRefGoogle Scholar
  144. 144.
    Zero DT, Raubertas RF, Fu J, et al. Fluoride concentrations in plaque, whole saliva, and ductal saliva after application of home-use topical fluorides. J Dent Res 1992; 71(11): 1768–75PubMedCrossRefGoogle Scholar
  145. 145.
    Lagerlöf F, Ekstrand J, Rölla G. Effect of fluoride addition on ionized calcium in salivary sediment and in saliva. Scand J Dent Res 1988; 96(5): 399–404PubMedGoogle Scholar
  146. 146.
    Dawes C, Weatherell JA. Kinetics of fluoride in the oral fluids. J Dent Res 1990; 69: 638–44PubMedGoogle Scholar
  147. 147.
    ’S-Gravenmade EJ, Roukema PA, Panders AK. The effect of mucin-containing artificial saliva on severe xerostomia. Int J Oral Surg 1974; 3(6): 435–9PubMedCrossRefGoogle Scholar
  148. 148.
    Shannon IL, McCrary BR, Starcke EN. A saliva substitute for use by xerostomic patients undergoing radiotherapy to the head and neck. Oral Surg Oral Med Oral Pathol 1977; 44(5): 656–61PubMedCrossRefGoogle Scholar
  149. 149.
    Regelink G, Vissink A, Reintsema H, et al. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998; 29(6): 383–8PubMedGoogle Scholar
  150. 150.
    Visch LL, ’S-Gravenmade EJ, Panders AK, et al. Adouble-blind crossovertrial of CMC- and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg 1986; 15(4): 395–400PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Timo O. Närhi
    • 1
    • 2
  • Jukka H. Meurman
    • 3
  • Anja Ainamo
    • 3
  1. 1.Sector of Oral Function and Prosthetic DentistryUniversity of NijmegenNijmegenThe Netherlands
  2. 2.Institute of DentistryUniversity of TurkuTurkuFinland
  3. 3.Institute of DentistryUniversity of HelsinkiHelsinkiFinland

Personalised recommendations